Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2150931011 | Gefitinib 250mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
2158722017 | Gefitinib 250mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
3486589014 | Product containing gefitinib 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3493190015 | Product containing gefitinib 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3501821012 | Gefitinib 250 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3569691012 | Product containing only gefitinib 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3569692017 | Product containing only gefitinib 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3679262017 | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3679263010 | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
56902501000001113 | Gefitinib 250mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Iressa 250mg tablet | Is a | False | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Zentiva Pharma UK Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Wockhardt UK Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Genus Pharmaceuticals Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Accord Healthcare Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Sandoz Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Iressa 250mg tablets (Originalis B.V.) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Iressa 250mg tablets (AstraZeneca UK Ltd) | Is a | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gefitinib 250mg tablets 30 tablet | Has VMP | True | Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets